Sipuleucel-T for prostate cancer: The immunotherapy era has commenced

Carlo Buonerba, Matteo Ferro, Giuseppe Di Lorenzo

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Sipuleucel-T for prostate cancer: The immunotherapy era has commenced'. Together they form a unique fingerprint.

Medicine & Life Sciences